Prime Medicine, Inc. (PRME) KPIs and segments

PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$4.27+0.38 (+9.77%)

Close on Nov 13, 2026Market cap $774.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Prime Medicine's business

Coming soon

This tab will track the numbers specific to Prime Medicine's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?